Exploring the Use of Cost-Benefit Analysis to Compare Pharmaceutical Treatments for Menorrhagia.

ABSTRACT:

Background

The extra-welfarist theoretical framework tends to focus on health-related quality of life, whilst the welfarist framework captures a wider notion of well-being. EQ-5D and SF-6D are commonly used to value outcomes in chronic conditions with episodic symptoms, such as heavy menstrual bleeding (clinically termed menorrhagia). Because of their narrow-health focus and the condition's periodic nature these measures may be unsuitable. A viable alternative measure is willingness to pay (WTP) from the welfarist framework.

Objective

We explore the use of WTP in a preliminary cost-benefit analysis comparing pharmaceutical treatments for menorrhagia.

Methods

A cost-benefit analysis was carried out based on an outcome of WTP. The analysis is based in the UK primary car

SUBMITTER: Sanghera S 

PROVIDER: S-EPMC4559088 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature